http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6852688-B2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_76ba102ea9c02b6633d64bf09c5b89a4 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-31 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-31 |
| filingDate | 2001-03-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2005-02-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8b4f0aef02b4706a57531cf16d343533 |
| publicationDate | 2005-02-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-6852688-B2 |
| titleOfInvention | Compositions for treating diabetic retinopathy and methods of using same |
| abstract | The subject invention provides novel methods and materials for treating diabetic retinopathy. One embodiment of the subject invention involves the co-administration of a somatostatin, or analogue thereof, and a thryoid-related substance such as thyroxine. Somatostatin or thyroid-related substance can be administered in combination, or separately through the same or different modes of administration. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7691411-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7052717-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004013725-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004219218-A1 |
| priorityDate | 2000-03-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 203.